| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00066-009-2026-4 |
| P698 | PubMed publication ID | 20082181 |
| P2093 | author name string | Claus Mayer | |
| H Peter Rodemann | |||
| Klaus Dittmann | |||
| P2860 | cites work | High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis | Q79947978 |
| Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma | Q95788188 | ||
| Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression | Q24292840 | ||
| Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor | Q24314620 | ||
| Tyrosine phosphorylation controls PCNA function through protein stability | Q24317732 | ||
| Extracellular heat shock protein 70 mediates heat stress-induced epidermal growth factor receptor transactivation in A431 carcinoma cells | Q24319679 | ||
| The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment | Q28142021 | ||
| A novel ADP-ribosylation like factor (ARL-6), interacts with the protein-conducting channel SEC61beta subunit | Q28145489 | ||
| The multiple faces of caveolae | Q29618099 | ||
| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
| Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. | Q30437778 | ||
| Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade | Q33410126 | ||
| Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. | Q34326386 | ||
| Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression | Q35094456 | ||
| Mechanisms of DNA double strand break repair and chromosome aberration formation | Q35783199 | ||
| Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer | Q35928801 | ||
| Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis | Q35979121 | ||
| Protein translocation across biological membranes | Q36328629 | ||
| Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression | Q36798731 | ||
| An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). | Q36840684 | ||
| Biology of interactions: antiepidermal growth factor receptor agents | Q36935078 | ||
| The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target | Q36981225 | ||
| Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer | Q36992266 | ||
| Radiation-induced EGFR-signaling and control of DNA-damage repair | Q37024025 | ||
| Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma | Q37104779 | ||
| The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer | Q37235527 | ||
| Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer | Q37282661 | ||
| Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today? | Q37368697 | ||
| Molecular targeted treatment and radiation therapy for rectal cancer | Q37511793 | ||
| Co-regulation of B-Myb expression by E2F1 and EGF receptor | Q38318606 | ||
| Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. | Q39940485 | ||
| Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation | Q40044976 | ||
| Validation of HB-EGF and amphiregulin as targets for human cancer therapy. | Q40049169 | ||
| DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients. | Q40097743 | ||
| Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis | Q40104227 | ||
| Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma. | Q40133869 | ||
| Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor | Q40237882 | ||
| Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. | Q40259700 | ||
| Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking | Q40331226 | ||
| Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis | Q40395185 | ||
| Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway | Q40396956 | ||
| Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity | Q40396981 | ||
| Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase | Q40401323 | ||
| Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. | Q40467153 | ||
| Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae | Q40531770 | ||
| Nuclear localization of EGF receptor and its potential new role as a transcription factor | Q40782527 | ||
| The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR. | Q40899042 | ||
| Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents | Q41077480 | ||
| Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab | Q42524527 | ||
| 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor | Q44104172 | ||
| Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation | Q45106730 | ||
| Growth of intestinal epithelium in organ culture is dependent on EGF signalling | Q45225450 | ||
| Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC. | Q45284781 | ||
| Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinoma. | Q46240826 | ||
| Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity. | Q46408833 | ||
| Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray | Q46535704 | ||
| Out of breath, asleep at the wheel | Q48481760 | ||
| Search for heavy long-lived particles that decay to photons at CDF II. | Q50891660 | ||
| Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. | Q52578812 | ||
| Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. | Q53534489 | ||
| C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. | Q53993143 | ||
| Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells | Q64389144 | ||
| The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma | Q73091527 | ||
| In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody | Q73483324 | ||
| Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors | Q78192920 | ||
| Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer | Q79385733 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2009-12-28 | |
| P1433 | published in | Strahlentherapie und Onkologie | Q15724604 |
| P1476 | title | Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function | |
| P478 | volume | 186 |
| Q36972817 | A genetic view of laryngeal cancer heterogeneity |
| Q30596960 | A putative pH-dependent nuclear localization signal in the juxtamembrane region of c-Met |
| Q38118934 | Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance |
| Q60922784 | COPI-Mediated Nuclear Translocation of EGFRvIII Promotes STAT3 Phosphorylation and PKM2 Nuclear Localization |
| Q26771165 | Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization |
| Q39300555 | Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro |
| Q34077207 | Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells |
| Q38106985 | DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy |
| Q34283213 | Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma |
| Q53284577 | EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact. |
| Q53211347 | Erlotinib-induced rash spares previously irradiated skin. |
| Q42085614 | Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor. |
| Q37269081 | HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth |
| Q37688876 | Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity |
| Q37690877 | Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application. |
| Q39097617 | Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line |
| Q48269479 | Models of human adamantinomatous craniopharyngioma tissue: Steps toward an effective adjuvant treatment. |
| Q31162700 | Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response |
| Q36617162 | Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma |
| Q36162605 | Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family |
| Q39602655 | Omega-3 fatty acid supplementation in cancer therapy : does eicosapentanoic acid influence the radiosensitivity of tumor cells? |
| Q38539957 | Opportunities and challenges of radiotherapy for treating cancer |
| Q45875804 | Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway |
| Q54341722 | Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. |
| Q35551805 | Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer |
| Q44294451 | Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer |
| Q37858343 | Protein kinase Cε as a cancer marker and target for anticancer therapy |
| Q34076405 | Protein mislocalization: mechanisms, functions and clinical applications in cancer |
| Q83964708 | Relapsing high grade mucoepidermoid carcinoma. Long-lasting complete response following reirradiation and EGFR blockade |
| Q38047648 | Reversion of the ErbB malignant phenotype and the DNA damage response. |
| Q38751317 | Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage. |
| Q37417599 | Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking |
| Q24304487 | The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents |
| Q34294881 | Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report |
| Q54548371 | [Effection and mechanism of radiosensitivity of non-small cell lung cancer cell line H358 following gefitinib treatment]. |
| Q54490610 | [Experimental tumor therapy]. |
Search more.